| Issue Date | Title | Author(s) |
| 2016 | Cost effectiveness of case-finding strategies for drug treatment in primary prevention of cardiovascular disease: a modelling study | Crossan, C; Lord, J; Ryan, R; Nherera, L; Marshall, T |
| 2015 | Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation | Crossan, C; Tsochatzis, EA; Longworth, L; Gurusamy, K; Davidson, B; RodrÃguez-Perálvarez, M; Mantzoukis, K; O'Brien, J; Thalassinos, E; Papastergiou, V; Burroughs, A |
| 7-Oct-2015 | Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation | Crossan, C; Tsochatzis, EA; Longworth, L; Gurusamy, K; Papastergiou, V; Thalassinos, E; Mantzoukis, K; Rodriguez-Peralvarez, M; O'Brien, J; Noel-Storr, A; Papatheodoridis, GV; Davidson, B; Burroughs, AK |
| 2014 | Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C | Tsochatzis, EA; Crossan, C; Longworth, L; Gurusamy, K; Rodriguez-Peralvarez, M; Mantzoukis, K; O'Brien, J; Thalassinos, E; Papastergiou, V; Noel-Storr, A; Davidson, B; Burroughs, AK |
| 2014 | Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models right | Tsochatzis, EA; Crossan, C; Longworth, L |
| 2013 | Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project | Lord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, SJE; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F |
| 2013 | Economic modelling of diagnostic and treatment pathways in NICE clinical guidelines: the MAPGuide project | Lord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, S; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F |
| 2015 | Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICE | Greenhalgh, J; Longworth, L; Crossan, C; Singh, J; Bagust, A; Beale, S; Richardson, M; Banks, L; Kotas, E; Hall, M |
| 14-Mar-2018 | A Protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study | Crossan, C; Dehbi, HM; Williams, H; Poulter, N; Rodgers, A; Jan, S; Thom, S; Lord, J |
